Genomed Spólka Akcyjna reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was PLN 7.2 million compared to PLN 6.08 million a year ago. Net income was PLN 1.38 million compared to PLN 0.516341 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28 PLN | -.--% | -.--% | -6.04% |
1st Jan change | Capi. | |
---|---|---|
-6.04% | 9.39M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- GEN Stock
- News Genomed Spólka Akcyjna
- Genomed Spólka Akcyjna Reports Earnings Results for the Fourth Quarter Ended December 31, 2023